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Tuesday, February 5, 2013 359agating in human CaV1.2 channels, we have optically tracked the activation of
the S4 helices of repeats I, III and IV by site-directed fluorescent labeling of
introduced Cysteines with thiol-reactive probes. The channels were co-
expressed with their modulatory subunits b3 and a2d in Xenopus oocytes. Ionic
current and fluorescence emission were simultaneously recorded using the cut-
open oocyte voltage clamp fluorometry technique. Prior voltage-clamp, oo-
cytes were injected with 100 nl 80 mM BAPTA.4K, to prevent the activation
of endogenous Ca2þ-gated Cl channels. The extracellular solution contained
2 mMBa2þ or 10 mMCa2þ as charge carrier. Gating currents were recorded by
replacing Ca2þ or Ba2þ with Co2þ. 0.1 mM ouabain was added to abolish Naþ/
Kþ ATPase non-linear charge movement. Voltage-dependent fluorescence
changes (DF) were reported by fluorophores attached to substituted Cysteines
at the extracelular end of the S4 segment in repeats I, III and IV, tracking local,
voltage-dependent conformational rearrangements. The voltage dependence of
observed fluorescence deflections preceded ionic activation, reporting repeat-
specific VSD transitions taking place during shut states of the channel. Pro-
longed sojourns at depolarized potentials (þ50 mV) shifted the voltage-
dependence of reported DF to more hyperpolarized potentials by >50mV, re-
capitulating previously-characterized gating current properties. In summary,
we report the first optical characterization of VSD conformational changes in
a human voltage-gated Ca2þ channel, revealing repeat-specific voltage- and
time-dependent properties.
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Ca2þ influx through L-type (CaV1.2) channels in heart regulates excitation-
contraction (EC) coupling, action potential duration, and gene expression.
This versatility of L-type channels in heart is hypothesized to be mediated
in part by differential sub-cellular compartmentalization and hormonal modu-
lation of distinct CaV1.2 channel pools in cardiac myocytes. Such prevailing
hypotheses are best tested directly in cardiac myocytes, since their unique
cyto-architecture and signaling environment cannot be replicated in heterolo-
gous cells. There are two major hurdles: first, the large size of pore-forming
a1C subunits exceeds the packaging capacity of viral vectors, necessary to
express exogenous CaV1.2 channels in adult cardiac myocytes; second,
endogenous channels are a source of confounding contaminating signals. To
overcome these limitations, we focused on functionally reconstituting two
separately expressed moieties of the channel using a novel split-intein-
mediated protein splicing approach. In HEK 293 cells, split-intein fragments
were trans spliced to generate full-length a1C as determined by Western
blot. When co-expressed with auxiliary b subunits, trans-spliced a1C trafficked
normally to the cell surface and yielded robust whole-cell currents (ICa). The
split-intein fragments were readily incorporated into adenoviral vectors which
when used to infect adult myocytes yielded trans-spliced a1C that was detected
at the cell surface. To isolate exogenous ICa, we introduced mutations that
reduced dihydropyridine sensitivity of trans-spliced a1C (a1CDHP-). In the pres-
ence of 10 mM nifedipine, myocytes expressing trans-spliced a1CDHP- yielded
significantly larger currents than controls expressing trans-spliced a1C. The
results demonstrate a novel approach to robustly engineer the pore-forming
a1C subunit composition of CaV1.2 channels in cardiac myocytes, removing
a longstanding technical obstacle to L-type channel structure-function studies
in heart.Platform: Protein Assemblies & Aggregates
1841-Plat
Toxic Intermediates in Islet Amyloid Formation: Analysis of IAPP
Mutants Reveals a Correlation between Lag Time and Toxicity
Ping Cao1, Andisheh Abedini2, Annette Plesner3, Ann Marie Schmidt2,
Daniel Raleigh1.
1Stony Brook University, Stony Brook, NY, USA, 2NYU School of
Medicine, New York, NY, USA, 3University of British Columbia,
Vancouver, BC, Canada.
Islet amyloid polypeptide (IAPP, Amylin) is responsible for amyloid formation
in type 2 diabetes and in islet cell transplants. The mechanism of IAPP toxicity
is poorly understood. Here we identify and characterize the toxic species
produced during amyloid formation by human IAPP. using a combination of
time-dependent biophysical and biological assays, we show that the transiently
populated pre-fibrillar intermediates formed in the early phase of amyloid
formation are toxic and they are loosely packed with very modest amountsof secondary structure. The only known natural mutation found in mature
human IAPP is a Ser20-to-Gly mis-sense mutation, which appears to be asso-
ciated with an increased risk of early-onset type 2 diabetes. We demonstrate
that the mutant accelerates amyloid formation under physiologically relevant
conditions. We rationally design another variant at residue 20, S20K-IAPP,
which is much slower to aggregate with an 18-fold longer lag phase and inhibits
wild type amyloid formation. The pronounced effects of the Ser20 mutants
highlight the sensitivity of amyloid formation to the identity of position 20.
By comparing the kinetics and toxicity profiles of the two Ser20 mutants to
wild type IAPP, we demonstrate that changes in the length of the lag phase
directly correlate with changes in the onset and the duration of toxicity. Our
findings provide direct evidence that the toxic species are transient intermedi-
ates and have implications for the treatment of type 2 diabetes and other
amyloid related diseases.
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Accumulating evidences suggest that many neurodegenerative diseases includ-
ing Alzheimer’s disease (AD) are linked with cytotoxic diffusible aggregates of
amyloid proteins, which are metastable intermediate species in protein misfold-
ing. Despite increasing importance of the amyloid intermediates, very little has
been known on their structures, relationship with amyloid fibril, and pathogenic
functions. This work presents a site-specific structural study on an intermediate
called amylo-spheroid (ASPD)(1) for 42-residue Alzheimer’s b (Ab(1-42)) by
solid-state NMR (SSNMR), which offers means to characterize metastable
amyloid intermediates.(2) As the ASPD level in a brain correlates with the se-
verity of AD, ASPD is likely an intermediate pathogenically relevant to AD.(1)
We demonstrate that detailed structural examination by 13C SSNMR is possible
on synthetic ASPD that well mimics native ASPD isolated from a brain extract
from an AD patient. Electron micrograph and immunological analyses using an
ASPD-specific ‘‘conformational’’ antibody confirm that morphologies and con-
formations of the synthetic ASPD used for the present NMR analysis are sim-
ilar to native ASPD. 13C SSNMR chemical-shift analysis over 20 residues
demonstrated that ASPD is made of a homogeneous conformer that is largely
composed of b-sheet structure. An inter-strand 13CO-13CO distance measure-
ment suggests that the ASPD involves a parallel b-sheet arrangement despite
the fact that ASPD does not bind to fibril-specific dyes such as thioflavin-T.
The structural features of ASPD will be compared with those of amyloid fibril
for Ab(1-42), which were elucidated by SSNMR analysis. The approach pre-
sented here is likely to open an avenue to examine structural details of various
amyloid intermediate species pathologically relevant to AD or other amyloid
diseases, for which structures have been poorly characterized.
References
1. Hoshi M., et al. (2009) J. Biol. Chem. 284:32895-32905.
2. Ishii Y, et al. (2007) Nat. Struct. Mol. Biol. 14:1157-1164.
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The proteolytic cleavage of the transmembrane amyloid precursor protein (APP)
produces amyloid-b peptides (Ab) that vary from 38 to 43 amino acids in length.
Two of these peptides, Ab1-40 and Ab1-42, are the major components of the ex-
tracellular amyloid plaques characteristic of Alzheimer’s disease (AD). Within
these plaques, the Ab is found aggregated into long polymeric assemblies rich in
b-sheet structure that are known as amyloid fibrils. Although the correlation
between plaque load and disease severity is poor there is strong evidence that
small soluble oligomers of Ab formed during the early stages of the aggregation
process are the agents of AD-associated neurotoxicity (1). Single molecule
fluorescence techniques have the potential to resolve the size and structural
heterogeneity of these oligomers, which are often difficult to discern by ensem-
ble methods. Most importantly, they allow the characterisation of small oligo-
meric species at the nucleation stage of the aggregation as the structures of
amyloid seeds remain ambiguous (2). Equimolar mixtures of Ab1-42 singly
labelled with either HiLyteFluor-488 or HiLyteFluor-647 were studied using
360a Tuesday, February 5, 2013single molecule fluorescence confocal microscopy and FRET, allowing the
characterisation of oligomers present during aggregation of monomers and dis-
aggregation of fibrils. Additionally, we have extended our single-molecule stud-
ies to examine the species formed during the co-aggregation of Ab1-40 and Ab1-
42 to understand the interaction at physiological concentrations and ratios. The
thorough detection and characterisation of these potentially toxic oligomeric
species provides a basis with which to screen therapeutic agents and other mod-
ulators of aggregation in vitro which could inform in vivo studies in the future.
1. F. Chiti, C.M. Dobson, Annu. Rev. Biochem. 75, 333-366 (2006)
2. A. Orte et al, PNAS, 105, 14424-14429 (2008)
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In type 2 diabetics, the hormone amylin misfolds into amyloid plaques impli-
cated in the destruction of the pancreatic b-cells that make insulin and amylin.
The pH-dependence of fibril formation affects fibrillization kinetics, fibril mor-
phology, and possibly toxicity. Amylin is stored in b-cell secretory granules at
pH 5.5 and is released into the extracellular matrix at pH 7.4. There are two
ionizable residues in amylin: the a-amino group and His 18. Our approach to
measuring the pKa values for these sites has been to look at the pH dependence
of fibrillization in amylin variants that have only one of the groups: NAc-
amylin (for His18) and H18R (for the N-terminus). The fibril-specific dye
thioflavin-T (ThT) was used to monitor kinetics. The pKa of His18 is lowered
to 5.1 in the fibrils, compared to the random coil value of 6.5. The lowered pKa
is due to the unfavorable burial of a charge, and electrostatic repulsion between
positively charged His18 residues on neighboring amylin molecules in the
fibril. For H18R, which can only be protonated at the N-terminus, we see
a pKa ~8 due to the N-terminus but a second pKa of ~4.5 due to protonation
of ThT. We confirmed this with the amylin-derived peptide NAc-
SNNFGAILSS-NH2 which has no titratable groups but still shows a pKa of
4.5 due to ThT. A pKa of 1.9 for free ThT was determined by NMR but with
fluorescence we are monitoring the excited-state of the amyloid-bound dye
which has a perturbed pKa. By using alternative methods to follow fibrillization
such as the dye Nile Red or turbidimetry we were able to distinguish between
the effects. Large differences in reaction kinetics were observed between the
different methods, due to charges on the dyes, which affect fibril formation
much like charges on the protein.
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One of the main pathological symptoms for Frontotemportal Dementia and
Parkinsonism linked to chromosome 17 (FTDP-17) is the accumulation of
neurofibrillary tangles in the brain via amyloid aggregation of the Tau protein.
It is well known that this process is accelerated in the presence of Ab. However,
the molecular mechanisms underlying the interactions between Ab and Tau
protein are currently not well understood. One of the most well-known muta-
tions in the tau protein that is related to FTDP-17 is the DK280 mutant. In
our work, we have studied the effect of this mutation on the tau protein’s pro-
pensity for aggregation in the absence and with the presence of Ab. We con-
structed a set of molecular oligomer models based on previous solid-state
NMR measurements and molecular dynamics simulations. Our results suggest
that with the presence of Ab, the mutated tau - Ab complex occupies a rugged
conformational landscape. The mutated tau oligomers that are stabilized by Ab
oligomers, preferred to interact as double layer structures instead of single layer
structures. However, in the absence of Ab, the conformational landscape of mu-
tated tau is characterized only by one preferred structure. These new insights
cast light on the interactions between amyloids in FTDP-17(as well as in other
neurodegenerative diseases) and may offer new strategies for future pharmaco-
logical studies that aim to ameliorate the interactions between amyloids in
FTDP-17. The research leading to these results has received funding from
the European Union Seventh Framework Programme (FP7/2011) under grant
agreement 303741.
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George Mason University, Manassas, VA, USA.Molecular biomarkers such as FDDNP can provide early diagnosis of Alz-
heimer’s disease (AD). These biomarker ligands are designed to interact with
aggregation-prone Ab peptides implicated in AD onset. While numerous exper-
imental observations have demonstrated FDDNP binding to Ab in vitro and
in vivo, molecular details of binding mechanism are currently unavailable. In
our study, we use explicit solvent replica exchange molecular dynamics to ex-
amine FDDNP binding to Ab10-40 monomer in all-atom detail. We found that at
both high and low concentrations, FDDNP binds with high affinity to Ab
sequence locations near the central hydrophobic cluster and the C-terminal.
Analysis of ligand-Ab interactions at both concentrations identifies hydropho-
bic effect as a main binding factor. However, with the increase in ligand con-
centration the interactions between FDDNP molecules also become important
due to strong FDDNP self-aggregation propensity and few specific binding
locations. As a result, FDDNP ligands partially penetrate the core of Abmono-
mer forming large self-aggregated clusters. Ligand self-aggregation does not
affect hydrophobic interactions as a main binding factor or the location of bind-
ing sites in Ab. Lastly, using Ab conformational ensemble in ligand-free water
as a reference we show that FDDNP induces minor changes in Ab secondary
structure. However, FDDNP significantly alters the tertiary fold in a concentra-
tion dependent manner by redistributing long-range side chain interactions.
Because FDDNP does not change Ab secondary structure, we argue that it is
likely to provide unbiased imaging of Ab aggregates.
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A vast number of protein misfolding diseases are characterized by the forma-
tion of nanoscale protein aggregates generally termed amyloids. Such diseases
include Alzheimer’s disease (AD), Huntington’s disease (HD), and type 2 di-
abetes. While the precise mechanism by which amyloidogenic aggregates are
toxic remains unclear, various amyloid-forming proteins interact strongly
with lipid membranes. We investigated how mechanical properties of model
total brain lipid extract bilayers are altered when exposed to different
amyloid-forming proteins (Aß, huntingtin, synthetic polyQ peptide, and amy-
lin) utilizing in situ tapping mode atomic force microscopy (AFM) and scan-
ning probe acceleration microscopy (SPAM). The advantage of the SPAM
technique is that provides nanoscale spatially resolved maps of tip/sample tap-
ping forces, which are directly correlated to mechanical properties of the sur-
face. As a result, mechanical changes of lipid membranes can be mapped
and correlated with changes in surface topography associated with protein ag-
gregation. using this technique, we demonstrate that lipid bilayer structure is
disrupted by amyloid-forming proteins. Disrupted regions of the bilayer were
associated with decreased compression modulus and reduced adhesion to the
AFM probe. Both of these observed mechanical changes are consistent with
a decrease in the packing efficiency of the lipids within the bilayer. The inter-
pretation of the mechanical changes in the lipid bilayers as measured by the
SPAM technique were validated via numerical simulations of the tip/surface
force interaction under a variety of conditions. These changes in bilayer
mechanical properties associated with exposure to amyloid forming proteins
may represent a common mechanism leading to membrane dysfunction in pro-
tein misfolding diseases.
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The assembly of the sphingomyelin (SM)-binding pore-forming toxin (PFT),
lysenin, on SM/cholesterol bilayer was examined by high-speed atomic force
microscopy (HS-AFM). Previous studies suggest that lysenin oligomerizes
after binding to SM and forms a honeycomb structure. The HS-AFM images
of SM/ cholesterol bilayer preincubated with lysenin exhibited the honeycomb
assembly of the lysenin oligomers. The time-lapse AFM images revealed that
the honeycomb formation took place quickly. During honeycomb formation
most of the oligomers underwent reorganization either by dissociating into
monomers or by rapidly diffusing along the membrane in less than a second.
In the period of reorganization, the mobile oligomers arranged into a static,
well-ordered lattice. Once this static layer was formed, the lysenin molecules
were firmly bound to the SM/cholesterol bilayer and the oligomers neither dis-
sociated nor diffused. Our results revealed the dynamic nature of the oligomers
of a lipid binding toxin during honeycomb formation.
